| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.0038 | 1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |